CELEGENCE LLC
CELEGENCE LLC, headquartered in the United States, is a leading provider in the life sciences and healthcare industry, specialising in innovative solutions for clinical trials and regulatory compliance. Founded in 2015, CELEGENCE has rapidly established itself as a trusted partner for pharmaceutical and biotechnology companies, offering a suite of services that includes data management, clinical trial support, and regulatory consulting. With a commitment to enhancing operational efficiency and ensuring compliance, CELEGENCE's unique approach combines advanced technology with deep industry expertise. The company has achieved significant milestones, including successful collaborations with major industry players and recognition for its contributions to improving clinical outcomes. CELEGENCE continues to solidify its market position through a focus on quality, innovation, and client satisfaction, making it a prominent name in the life sciences sector.
DitchCarbon Score
How does CELEGENCE LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CELEGENCE LLC's score of 6 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CELEGENCE LLC's reported carbon emissions
Celegence LLC, headquartered in the United States, has set ambitious climate commitments aimed at significantly reducing its greenhouse gas emissions. Although specific emissions data for the most recent year is not available, the company has established a target to reduce its Scope 1 and Scope 2 emissions by 42% by the year 2030, using 2023 as the baseline year. This target has been validated through a streamlined process designed for small and medium-sized enterprises (SMEs) and aligns with the necessary reductions to limit global warming to 1.5°C. In addition to its focus on Scope 1 and Scope 2 emissions, Celegence LLC is also committed to measuring and addressing its Scope 3 emissions, which encompass indirect emissions from its value chain. These initiatives reflect the company's proactive approach to climate action within the pharmaceuticals, biotechnology, and life sciences sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CELEGENCE LLC is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
